1.
Lancet
; 397(10287): 1791-1792, 2021 05 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33932327
2.
J Law Med Ethics
; 50(S2): 17-25, 2022.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36889344
RESUMEN
To address the complex challenge of global antimicrobial resistance (AMR), a pandemic treaty should include mechanisms that 1) equitably address the access gap for antimicrobials, diagnostic technologies, and alternative therapies; 2) equitably conserve antimicrobials to sustain effectiveness and access across time and space; 3) equitably finance the investment, discovery, development, and distribution of new technologies; and 4) equitably finance and establish greater upstream and midstream infection prevention measures globally. Biodiversity, climate, and nuclear governance offer lessons for addressing these challenges.